PharmaCielo Ltd. announced that it has completed initial shipments to two customers in Brazil following an audit to confirm PharmaCielo's compliance with Brazilian Good Manufacturing Practices standards. The first shipment recently arrived at one of Brazil's largest Phyto-Therapeutics companies. This customer intends to integrate PharmaCielo's APIs into custom formulations for current and future product registry and sale in the local market. The second shipment recently arrived at a large Pharmaceutical company that already has a CBD product in-market and intends to use PharmaCielo as a key supplier.